212 related articles for article (PubMed ID: 15754122)
1. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
Roscoe JA; Morrow GR; Hickok JT; Mustian KM; Griggs JJ; Matteson SE; Bushunow P; Qazi R; Smith B
Breast Cancer Res Treat; 2005 Feb; 89(3):243-9. PubMed ID: 15754122
[TBL] [Abstract][Full Text] [Related]
2. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment.
Roscoe JA; Morrow GR; Hickok JT; Bushunow P; Matteson S; Rakita D; Andrews PL
Support Care Cancer; 2002 May; 10(4):329-36. PubMed ID: 12029433
[TBL] [Abstract][Full Text] [Related]
3. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
Baldwin D; Bridgman K; Buis C
J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
[TBL] [Abstract][Full Text] [Related]
4. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
Navari RM; Brenner MC; Wilson MN
Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
[TBL] [Abstract][Full Text] [Related]
5. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.
Payne JK; Held J; Thorpe J; Shaw H
Oncol Nurs Forum; 2008 Jul; 35(4):635-42. PubMed ID: 18591167
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
Gottlieb SS; Kop WJ; Thomas SA; Katzen S; Vesely MR; Greenberg N; Marshall J; Cines M; Minshall S
Am Heart J; 2007 May; 153(5):868-73. PubMed ID: 17452166
[TBL] [Abstract][Full Text] [Related]
7. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.
Ehde DM; Kraft GH; Chwastiak L; Sullivan MD; Gibbons LE; Bombardier CH; Wadhwani R
Gen Hosp Psychiatry; 2008; 30(1):40-8. PubMed ID: 18164939
[TBL] [Abstract][Full Text] [Related]
9. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF
J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
11. The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment.
Heras P; Kritikos K; Hatzopoulos A; Kritikos N; Heras V; Mitsibounas D
Am J Ther; 2013; 20(3):254-6. PubMed ID: 19262364
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
14. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
[TBL] [Abstract][Full Text] [Related]
15. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
[TBL] [Abstract][Full Text] [Related]
16. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?
Brown P; Clark MM; Atherton P; Huschka M; Sloan JA; Gamble G; Girardi J; Frost MH; Piderman K; Rummans TA
Am J Clin Oncol; 2006 Feb; 29(1):52-8. PubMed ID: 16462503
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.
Byar KL; Berger AM; Bakken SL; Cetak MA
Oncol Nurs Forum; 2006 Jan; 33(1):E18-26. PubMed ID: 16470230
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program.
Morrow GR; Hickok JT; Roscoe JA; Raubertas RF; Andrews PL; Flynn PJ; Hynes HE; Banerjee TK; Kirshner JJ; King DK;
J Clin Oncol; 2003 Dec; 21(24):4635-41. PubMed ID: 14673053
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
Yates P; Aranda S; Hargraves M; Mirolo B; Clavarino A; McLachlan S; Skerman H
J Clin Oncol; 2005 Sep; 23(25):6027-36. PubMed ID: 16135471
[TBL] [Abstract][Full Text] [Related]
20. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
